Trial · NCT02738801
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Patients With Treatment-Emergent Adverse Events (AEs) | Placebo QD | 4 | Participants | ||
| Number of Patients With Treatment-Emergent Adverse Events (AEs) | GLPG1690 600 mg QD | 11 | Participants | ||
| Mean Maximum Observed Plasma Concentration (Cmax; Micrograms Per Milliliter [µg/mL]) of GLPG1690 | GLPG1690 600 mg QD | 6.06 | Standard Deviation 4.92 | µg/mL | |
| Median Time to Occurrence of GLPG1690 Cmax (Tmax; Hours [h]) | GLPG1690 600 mg QD | 4 | Full Range 1.5 to 6 | hours | |
| Mean Area Under the Plasma Concentration-Time Curve (AUC[t]; µg.h/mL) of GLPG1690 | GLPG1690 600 mg QD | 55.6 | Standard Deviation 46.6 | µg.h/mL | |
| Mean GLPG1690 Plasma Concentration Observed at Predose (Ctrough; µg/mL) | GLPG1690 600 mg QD | 0.624 | Standard Deviation 0.846 | µg/mL | |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | Placebo QD | Baseline | 0.4180 | Standard Error 0.1088 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | GLPG1690 600 mg QD | Baseline | 0.3311 | Standard Error 0.0670 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | Placebo QD | Day 28 | 0.3650 | Standard Error 0.0895 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | GLPG1690 600 mg QD | Day 28 | 0.1476 | Standard Error 0.0380 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | Placebo QD | Day 28 (1.5 hours postdose) | 0.4071 | Standard Error 0.1352 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | GLPG1690 600 mg QD | Day 28 (1.5 hours postdose) | 0.0479 | Standard Error 0.0120 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | Placebo QD | Day 28 (6 hours postodse) | 0.3402 | Standard Error 0.1373 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | GLPG1690 600 mg QD | Day 28 (6 hours postodse) | 0.0314 | Standard Error 0.0046 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | Placebo QD | Day 84 | 0.4080 | Standard Error 0.1090 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | GLPG1690 600 mg QD | Day 84 | 0.0898 | Standard Error 0.0160 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | Placebo QD | Day 98 | 0.4672 | Standard Error 0.1647 | peak area ratio |
| Mean Peak Area Ratio of Lysophosphatidic Acid (LPA) C18:2 Species in Blood | GLPG1690 600 mg QD | Day 98 | 0.5172 | Standard Error 0.1660 | peak area ratio |
| Mean Peak Area Ratio of LPA C18:2 Species in Bronchoalveolar Lavage Fluid (BALF) | Placebo QD | Baseline | 0.0026 | Standard Error 0.0011 | peak area ratio |
| Mean Peak Area Ratio of LPA C18:2 Species in Bronchoalveolar Lavage Fluid (BALF) | GLPG1690 600 mg QD | Baseline | 0.0009 | Standard Error 0.0002 | peak area ratio |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02738801/results